Patent name: A Chinese medicinal preparation for treating esophageal cancer.
Abstract: The invention provides a traditional Chinese medicine preparation for treating esophageal cancer, which is mainly composed of the following drugs. 5- 10 of radix aucklandiae, 0/0-/0/5 of poria cocos, 0.2-0.4 of natural bezoar, 5- 10 of bulbus Fritillariae cirrhosae, 3-9 of fructus amomi, 5- 15 of radix salviae miltiorrhizae, and radix asparagi. 0/5-20 parts of mint/kloc-0, 0/5 parts of Dendrobium/kloc-0, 0/30 parts of Polygonatum odoratum/kloc-0, 0/3-30 parts of Radix Rehmanniae, and 0/0-/kloc of Radix Adenophorae. 0.3-0.5 part of musk, 0/5-60 parts of Hedyotis diffusa/kloc-0, 3-9 parts of safflower, 5-/kloc-0 part of peach kernel, 3-/kloc-0 part of ginseng, 0/5-20 part of astragalus membranaceus/kloc-0, and 0 part of pilose antler/kloc-0. The effective rate of the traditional Chinese medicine preparation is 65438 000%, and the remarkable efficiency is over 90%. Generally, the drug is taken for 3-7 days, and most cancer patients can prolong their life by more than 3-8 years after taking the drug. It is very common for patients whose survival time exceeds 10 years. Therefore, compared with traditional Chinese and western medicines for treating esophageal cancer in the prior art, the invention has the characteristics of high curative effect, no toxic and side effects and the like, and has good popularization and use value.
Applicant: Qin Xudong
Address: 2500 13 No.41Shanda Road, Jinan City, Shandong Province
Inventor (Designer): Qin Xudong